Please assess the completion status of the following clinical trial:

Trial Title: Role of Mirtazapine in Ameliorating Sleep Disordered Breathing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults with SCI (\>6months after spinal cord injury) at the T6 level/above~* Non-injured adults~Exclusion Criteria:~* Pregnant and lactating females~* Heart failure, vascular disease, or stroke~* Advanced chronic obstructive pulmonary disease (COPD), liver disease, and chronic kidney disease~* BMI \>38 kg/m2~* Mechanical ventilation dependence

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Mirtazapine (Type: ACTIVE_COMPARATOR): The drug will be taken for a one week peroid.
- Placebo (Type: PLACEBO_COMPARATOR): The drug will be taken for a one week peroid.

Based on this trial design, predict the completion outcome and termination type (if applicable).